|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/24 | |||
| A61K 31/485 | |||
| A61P 25/04 |
| (11) | Number of the document | 2402005 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11178912.9 |
| Date of filing the European patent application | 2006-08-24 | |
| (97) | Date of publication of the European application | 2012-01-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-16 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 772466 P | 2006-02-10 | US | |
| 710772 P | 2005-08-24 | US |
| (72) |
BAICHWAL, Anand, US
SCIASCIA, Thomas, US
DIEHL, Donald, US
VOGLER, Brian, US
|
| (73) |
Endo Pharmaceuticals Inc.,
1400 Atwater Drive, Malvem PA 19355,
US
|
| (54) | Sustained release formulations of nalbuphine |
| Sustained release formulations of nalbuphine |